REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Gemolab Biologia Molecular y Clinico S.A.S. (Ecuador)

Main Activities: Medical and Diagnostic Laboratories
Full name: Gemolab Biologia Molecular y Clinico S.A.S. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Gemolab Biologia Molecular y Clinico S.A.S. is a company based in Ecuador, with its head office in Cuenca. It operates in the Medical and Diagnostic Laboratories sector. The enterprise was incorporated on August 21, 2023. The total number of employees is currently 8 (2024). From the latest financial highlights, Gemolab Biologia Molecular y Clinico S.A.S. reported a net sales revenue increase of 564.09% in 2024. Its total assets grew by 131.65% over the same period. In, 2024, the company’s net profit margin increased by 18.76%.

Headquarters
Calle Florencia Astudillo, 1-28
Cuenca; Azuay;

Contact Details: Purchase the Gemolab Biologia Molecular y Clinico S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Gemolab Biologia Molecular y Clinico S.A.S. report to view the information.
Registered Capital:
Purchase the Gemolab Biologia Molecular y Clinico S.A.S. report to view the information.
Financial Auditors:
Purchase the Gemolab Biologia Molecular y Clinico S.A.S. report to view the information.
Incorporation Date:
August 21, 2023
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Gemolab Biologia Molecular y Clinico S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
564.09%▲
Total operating revenue
564.09%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
98.89%▲
Total Assets
131.65%▲
Total Equity
-71.09%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
18.76%▲
Return on Equity (ROE)
29.98%▲
Quick Ratio
0.22%▲
Cash Ratio
-0.01%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo